Document
Academic Article
Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients
Generically Dependent Continuant
Article
Information Content Entity
RDF description of Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients - http://irises.unimi.it/resource/item/363447